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Background: Extensive chest wall resections can provoke a wide
variety of complications, in particular, complicated wound healing.
A lower complication rate will be achieved when local factors
contributing to wound healing can be identified and improved. The
aim of this study is to describe these factors, irrespective of prog-
nosis, survival, or systemic complications.
Methods: Retrospectively, the files of all patients undergoing an
extended chest wall resection in a single institute during a 20-year
period were retrieved. Patient demographics, use of preoperative
therapy, tumor histology, the type of prosthesis (if any), and post-
operative wound complications were recorded. Univariate and mul-
tivariate analysis were performed to identify factors contributing
significantly to wound healing problems.
Results: From January 1987 to December 2006, 220 patients un-
derwent a chest wall resection, defined as resection of at least one
rib, and/or part of the sternum. In 145 patients (66%) this procedure
was uneventful. Multivariate analysis showed that ulceration of
tumor and the use of omentum for soft tissue reconstruction com-
prised independent factors contributing to impaired wound healing.
Conclusion: Several factors leading to wound healing problems exist
preoperatively. In a multidisciplinary setting, these factors should be
weighed carefully against the possible benefits of an extended chest
wall resection. Especially when ulceration of a tumor exists, or when
omentum is considered for soft tissue reconstruction, increased risk on
wound healing problems occurs. For the majority of patients chest wall
resection will remain a safe and suitable procedure.
Key Words: Chest wall resection, Complications, Breast cancer,
Sarcoma, Wound healing.
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Chest wall resection (CWR) for voluminous tumors orradiation ulcers leads to soft tissue and skin loss, in
combination with a skeletal chest wall defect. To reconstruct
the bony skeletal lesions several artificial materials can be
used. Reconstruction is necessary to preserve the rigidity of
the chest wall and to prevent respiratory failure. Performing
an adequate soft tissue reconstruction is a challenging prob-
lem for which several techniques of tissue transfer can be
used, varying from rotation of adjacent healthy tissue into the
defect, to free vascularized muscle/tissue transplants combined
with a skin transplant. In patients with a persistent radiation ulcer
adequate debridement of devitalised or infected soft tissue is
essential before reconstruction and a prerequisite for successful
and stable long-term coverage of defects.
Primary tumors of the chest wall mainly consist of
sarcomas, both soft tissue and osteosarcoma. The overall
5-year survival after CWR for sarcomas is 64 to 87%.1–3
Survival after CWR for primary malignant tumors is depen-
dent on the histology of the tumor, the existence of free
resection margins and the absence of distant metastases.
Regarding the group of patients with recurrent lesions, breast
cancer is the main histology instigating CWR. As can be
expected, the prognosis after CWR for recurrent disease
varies widely depending on the selected patient group. The
overall survival at 3 and 5 years is, respectively, 41 and 18%,4
up to a 5 years survival of 48%5 in studies with heterogeneous
patient groups.6,7
Despite modern techniques for chest wall reconstruc-
tion complications after this procedure are reported in 37 to
46% of patients, though published series on complication
rates are of limited size, with only one publication describing
more than 100 patients.8 Reported perioperative mortality
seems to be low and does not exceed 1% in larger series. The
purpose of this study is to identify patient and tumor charac-
teristics that are predictive for failure of postoperative wound
healing. It will provide information concerning improvement
of preoperative patient selection and the use of reconstructive
techniques after CWR.
MATERIALS AND METHODS
Retrospectively, the medical files of all patients in
which a CWR was performed at the department of surgical
oncology of the Erasmus Medical Center/Daniel den Hoed
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Cancer Center, from January 1st, 1987 to December 31st
2006, were reviewed. Included were all patients that had
undergone a resection of at least one rib, and/or part of the
sternum. Skeletal reconstruction of the chest wall was per-
formed with several types of inlays during the 20 years of this
study. The first few years homologous dura mater was used
(Lyodura, B. Braun, Melsungen, FRG), later replaced by
Polyurethane (Neurpatch, B. Braun, Melsungen, FRG) as an
artificial inlay. In some cases Polyglactine (Vicryl) was used.
Patients operated after 2004 received a double layer polypro-
pylene-polytetrafluoroethylene mesh. No rigid prosthesis like
plates or bone grafts were used. Standard soft tissue recon-
struction was performed with an omentoplasty, unless pri-
mary closure could be established. In an earlier report oper-
ative and postoperative procedures are described in detail.9
The preoperative data retrieved from the original patient files
included patient demographics, use of preoperative chemo-
therapy, radiotherapy, hyperthermia, and/or doses of radia-
tion. Furthermore, tumor characteristics including histologic
type, diameter, and the presence of ulceration were retrieved
from the pathology reports. Data on surgical techniques were
obtained from operative reports and included the location of
the chest wall lesion, the number of ribs resected, additional
resections of lung parenchyma, and the methods for skeletal
and soft tissue reconstruction used. Complications were
graded according to the National Cancer Institute Common
Toxicity Criteria for Adverse Events, version 3.0 (CTCEA
3.0, http://ctep.cancer.gov/reporting/ctc.html) and defined as
perioperative if they occurred within 30 days after surgery.
This retrospective study covers a 20 years period of
patient data and was not written down to describe any kind of
research. It therefore does not include a statement of patient
consent, neither were the operations performed in a research
setting so they did not need the approval of Internal Review
Boards. Complications were considered serious in case they
prolonged hospital stay to over 2 weeks, in case a reoperation
was needed or in case the patient died of the complication.
Factors with potential prognostic value for the occurrence of
complications were univariately analyzed using 2 tests and
logistic regression. Odds ratios were estimated and 95%
confidence intervals were calculated. Backward-stepwise
multivariate logistic regression was performed using all fac-
tors that showed significance in the univariate analyses.
RESULTS
Patient, Tumor and Treatment Characteristics
Between 1987 and 2006, 220 patients were found
meeting our definition of a CWR. There were 163 women and
57 men, with a median age of 56 years (range, 22–81 years).
In Table 1 the patient’s baseline characteristics and distribu-
tion of histology is shown.
In all 92 patients in the breast cancer group a CWR was
performed for local recurrence. Thirty-six patients did not
have any radiotherapy preceding CWR. Twenty-nine patients
were treated previously with breast conserving surgery and
radiotherapy. The remaining 27 patients underwent preoper-
ative radiotherapy of the chest wall for recurrent disease, of
which 16 patients received preoperative hyperthermia as
well. All breast cancer patients had received some kind of
systemic therapy, either hormonal, chemotherapeutical, or
combinations of both. During the study period chemotherapy
regimes changed several times in accordance with the na-
tional guidelines. Sixty-six patients were operated for sarco-
matous tumors arising in the chest wall. Fifty-nine of these
patients had primary tumors. Neither the patients with pri-
mary soft tissue sarcoma, nor the patients with recurrent
disease had radiation therapy or chemotherapy before sur-
gery. Thirty-seven patients with sulcus superior tumors were
treated in a protocol including pre- and intraoperative radio-
therapy. The treatment protocol of this specific group has
been published before.10 The indication for CWR of 25-
patients consisted of various other types of cancer, and
radiation necrosis in the absence of cancer. Preoperative
ulceration of the tumor or chest wall was documented in 30
patients, almost all in patients with a history of breast cancer.
In 58 patients a pedicled omentoplasty was used with a split
skin graft to achieve wound closure, as described in earlier
reports of our group.11,12 Only in two cases a fasciocutaneous
transposition was performed to create an appropriate soft
tissue covering. In 129 patients an inlay was used as a skeletal
reconstruction of the chest wall.
Complications
In Table 2 the complications imposing the most severe
impact on the postoperative course are listed per patient. A
complete uneventful postoperative course was seen in 145
patients (66%). Serious complications defined as resurgery
(n  9), prolonged stay in the hospital or readmission (n 
28), or death (n  5) within 30 days from the operation were
TABLE 1. Baseline Patient, Tumor and Treatment
Characteristics of All 220 Patients
n %





60 yr 129 59
60 yr 91 41
Histology
Breast cancer 92 42
Sarcoma 66 30





Baseline patient treatment characteristics
Pedicled omentoplasty
Used 58 26
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seen in 42 patients (19%). In 24 patients an infection was
treated with antibiotics and in three patients an empyema
needed surgical drainage. Secondary wound necrosis oc-
curred in 17 patients; in 12 patients due to more than 50%
necrosis of the omentum. Loss of the artificial inlay was seen
in nine patients. A logistic regression analysis of the proba-
bility of presence of complications weighed against the pa-
tient characteristics was performed.
Univariate analysis results are shown in Table 3. Signifi-
cant factors in these analyses are indication for operation (p 
0.03), the use of omentum for reconstruction (p  0.001),
ulceration of the tumor (p  0.001), the dose of radiotherapy
51 Gy (p 0.008), and preoperative use of hyperthermia (p
0.002). Multivariate analysis showed that ulceration of tumor
and the use of omentum for reconstruction significantly pre-
dicted postoperative complications (Table 4).
Mortality
Five patients (2.3%) died as a result of postoperative
complications. Four patients died as a result of respiratory
complications, although in one of these four patients a CWR
was combined with a pneumonectomy. The fifth patient
underwent a large CWR for sarcoma, but died within a week
from pancreatitis.
DISCUSSION
This study was performed to identify factors influenc-
ing complication rates in the surgical management of chest
wall malignancies. The study focused on predictive factors
for the failure of wound healing rather than on survival
benefits.
Full-thickness chest wall resections leave a segment of
the chest wall vulnerable to paradoxical motion during res-
piration. Principally, full-thickness skeletal defects are to be
reconstructed with a rigid prosthesis to prevent impaired
respiratory function. The decision whether or not to recon-
struct the chest wall depends on the size and location of the
defect and whether the wound is infected. In our experience,
TABLE 4. Multivariate Logistic Regression Analysis of the
Probability of Presence of Complications
OR 95% CI p
Ulceration
No/yes 2.51 1.03–6.07 0.04
Omentum
No/yes 2.66 1.34–5.30 0.005
OR, odds ratio; CI, confidence interval.








Loss of inlay 9
Hemorrhage 8







TABLE 3. Univariate Logistic Regression Analyses of the
Probability of Presence (Pr) of Complications
Covariate n Pr (%) OR 95% CI p
Tumor 0.12
Mamma carcinoma 92 42 1
Sarcoma 66 24 0.43 0.22–0.87
Lung; sulcus superior 37 32 0.65 0.29–1.46
Others 25 32 0.64 0.25–1.63
Gender 0.43
Female 163 36 1
Male 57 30 0.77 0.40–1.48
Age 0.39
60 yr 129 32 1
60 yr 91 37 1.28 0.73–2.25
Indication 0.03
Curative 196 32 1
Palliative 24 54 2.54 1.07–5.98
Omentum 0.001
No 162 26 1
Yes 58 56 3.57 1.91–6.70
Operation resection 0.47
Not limited 179 35 1
Limited 41 29 0.76 0.36–1.60
Sternum resection 0.20
No 183 32 1
Yes 37 43 1.60 0.78–3.29
Ulceration 0.001
Absent 190 29 1
Present 30 63 4.13 1.85–9.25
BCT 0.24
No 171 32 1
Yes 49 41 1.48 0.77–2.85
Pre-CWR radiotherapy 0.09
No 140 30 1
Yes 80 41 1.64 0.92–2.91
Dose radiotherapy 0.008
51 Gy 155 29 1
51 Gy 65 47 2.21 1.22–4.02
Hyperthermia 0.002
No 200 31 1
Yes 20 65 4.13 1.57–10.86
Pre-CWR chemotherapy 0.23
No 171 32 1
Yes 49 41 1.50 0.78–2.88
OR, odds ratio; CI, confidence interval; BCT, breast conserving therapy; CRW,
chest wall resection.
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lesions less than 5 cm in size in any location on the chest wall
do not need a reconstruction. Posterior, defects up to 10 cm
can be closed without prosthesis because of the overlying
scapula covering the chest wall. All other defects are likely to
produce a paradox chest wall motion and require a rigid
reconstruction, although all rigid reconstructions should be
covered with soft tissue. For this reason omentoplasties, in
combination with a skin graft or (pedicled) myocutaneus flaps
are often used to cover the prosthesis on complex thoracic
defects. Since these soft tissue defects, especially in contam-
inated or irradiated fields, require well-vascularized tissue to
ensure primary wound healing, the ideal flap for coverage
will be thin with an abundance of tissue, pliable and well
vascularized. It should also be easily accessible with minimal
donor site morbidities. The omentum has been used since the
1903, when Senn13 reported his use of the omentum as a
protective wrapping for intestinal anastomoses.
We have been using omental pedicled flaps in a variety
of complex thoracic defects, however, the results show that
this reconstruction contributes to wound healing problems.
Although described as malleable and easy to mold, caution
should be taken when folding omentum; we found that
especially when the omentum had been folded on itself distal
flap necrosis occurred. We observed that omentoplasties
covering large chest wall defects are prone for necrosis
especially when postoperative infections occur.
Also the lack of structural support on the thorax ren-
dered the omentum subject to gravitational dropping and
subsequent partial necrosis. In this series, a mortality rate of
2% (5 of 220) is found, of which four patients died of
pulmonary complications related to the surgical procedure.
These findings are similar to the data currently available in
literature (4% in 262 patients),8 regardless of the fact that
several patients described in this study underwent extensive
resections. For example, in four patients an extended fore
quarter amputation was performed in a palliative setting,
resulting in one fatal outcome. In that specific patient the
extended fore quarter amputation was combined with a pneu-
monectomy. In an earlier study Weyant et al.8 describe four
deaths of 9 patients in who a CWR was combined with a
pneumonectomy. Clearly such an amputation can imply ma-
jor complications in patients with an impaired condition.
Few prior studies have analyzed risk factors for post-
operative complications after chest wall resection. Weynant
has shown that size of the chest wall defect is a predictor of
complications, and suggests that using rigid repair provokes
less pulmonary problems. The mechanisms leading to respi-
ratory insufficiency and failure of wound closure are weakly
understood. Especially, ulcerating tumors or radionecrotic
areas are at risk for postreconstructive wound healing failure.
Nowadays the majority of such defects will be repaired with
the use of local and regional musculocutaneous flaps, al-
though more complicated cases require increasingly sophis-
ticated reconstructive techniques.14 Losken et al.15 provide in
their rapport a reconstructive algorithm following large chest
wall defects with the use of vascularized flaps and prosthetic
material. The risk factors included in this study were age,
prior chemotherapy or radiotherapy, size of the chest wall
defect, preoperative ulceration of the defect, an additional
sternal or lung resection, type of prosthesis used in the
reconstruction, and type of soft tissue coverage. It is demon-
strated that ulceration of the tumor and covering the chest
wall defect with a pedicled omentoplasty are negative factors
in an uneventful postoperative course. Less convincing is the
adverse role of high dose preoperative radiotherapy, whether
or not in combination with hyperthermia.
This study has several limitations. First, this retrospec-
tive study covers a time period of 20 years in which surgical
and radiation techniques changed in time. Advances in pre-
operative work-up, anesthetic care, and perioperative man-
agement will have improved outcome of these patients over
years, and will continue to do so in the future. Second,
comorbidity was left out of the analysis, although it is known
that systemic disease like diabetes or vascular diseases can
have a significant impact on wound healing.
Furthermore, comparing this data with data available in
the literature is scarcely possible, since patient groups differ
to a great extent. Scoring systems for complications vary
widely in published studies. In 34% of our patients (75 of
220) a complication occurred of which 42 patients (19%)
experienced serious complications, defined as reoperation,
prolonged stay in the hospital, readmission, or death. It can be
complex to draw conclusions from this data. Patient selec-
tion, surgical techniques, and the prosthesis of choice
should be subject of careful consideration to prevent post-
operative complications. Nevertheless from the described
data it can be concluded that omentoplasty to cover the
chest wall prosthesis should be avoided if possible. The
choice for a myocutaneus flap, like a latissimus dorsi or
transverse rectus abdominus transposition should be en-
couraged in future reconstructions.
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